Human Pathology
Volume 37, Issue 1 , Pages 101-111 , January 2006

Maturation delay of germ cells in fetuses with trisomy 21 results in increased risk for the development of testicular germ cell tumors

  • Martine Cools, MD

      Affiliations

    • Department of Pathology, Josephine Nefkens Institute, Erasmus MC–University Medical Center, Daniel den Hoed, 3000 DR Rotterdam, The Netherlands
    • ,
  • Friedemann Honecker, MD

      Affiliations

    • Department of Pathology, Josephine Nefkens Institute, Erasmus MC–University Medical Center, Daniel den Hoed, 3000 DR Rotterdam, The Netherlands
    • Department of Oncology/Hematology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
    • ,
  • Hans Stoop, BSc

      Affiliations

    • Department of Pathology, Josephine Nefkens Institute, Erasmus MC–University Medical Center, Daniel den Hoed, 3000 DR Rotterdam, The Netherlands
    • ,
  • Joris D. Veltman, BSc

      Affiliations

    • Department of Pathology, Josephine Nefkens Institute, Erasmus MC–University Medical Center, Daniel den Hoed, 3000 DR Rotterdam, The Netherlands
    • ,
  • Ronald R. de Krijger, MD, PhD

      Affiliations

    • Department of Pathology, Josephine Nefkens Institute, Erasmus MC–University Medical Center, Daniel den Hoed, 3000 DR Rotterdam, The Netherlands
    • ,
  • Ewout Steyerberg, PhD

      Affiliations

    • Department of Public Health, Center for Clinical Decision Science, Erasmus MC–University Medical Center, 3000 DR Rotterdam, The Netherlands
    • ,
  • Katja P. Wolffenbuttel, MD

      Affiliations

    • Department of Pediatric Urology, Sophia Children's Hospital, Erasmus MC–University Medical Center, 3000 DR Rotterdam, The Netherlands
    • ,
  • Carsten Bokemeyer, MD, PhD

      Affiliations

    • Department of Oncology/Hematology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
    • ,
  • Yun-Fai Chris Lau, PhD

      Affiliations

    • Division of Cell and Developmental Genetics, Department of Medicine, VA Medical Center, University of California, San Francisco, CA 94121, USA
    • ,
  • Stenvert L.S. Drop, MD, PhD

      Affiliations

    • Department of Pediatric Endocrinology, Sophia Children's Hospital, Erasmus MC–University Medical Center, 3000 DR Rotterdam, The Netherlands
    • ,
  • Leendert H.J. Looijenga, PhD

      Affiliations

    • Department of Pathology, Josephine Nefkens Institute, Erasmus MC–University Medical Center, Daniel den Hoed, 3000 DR Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author.

Received 29 March 2005 ,Accepted 24 September 2005.

References 

  1. Satge D, Sommelet D, Geneix A, Nishi M, Malet P, Vekemans M. A tumor profile in Down syndrome. Am J Med Genet. 1998;78:207–216
  2. Dexeus FH, Logothetis CJ, Chong C, Sella A, Ogden S. Genetic abnormalities in men with germ cell tumors. J Urol. 1988;140:80–84
  3. Mann JR, Pearson D, Barrett A, Raafat F, Barnes JM, Wallendszus KR. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Cancer. 1989;1963:1657–1667
  4. Satge D, Sasco AJ, Cure H, Leduc B, Sommelet D, Vekemans MJ. An excess of testicular germ cell tumors in Down's syndrome: three case reports and a review of the literature. Cancer. 1997;80:929–935
  5. Jacobsen GK, Henriques UV. A fetal testis with intratubular germ cell neoplasia (ITGCN). Mod Pathol. 1992;5:547–549
  6. Dieckmann KP, Rube C, Henke RP. Association of Down's syndrome and testicular cancer. J Urol. 1997;157:1701–1704
  7. Smucker JD, Roth LM, Sutton GP, Hurteau JA. Trisomy 21 associated with ovarian dysgerminoma. Gynecol Oncol. 1999;74:512–514
  8. Rajpert-De Meyts E, Jorgensen N, Brondum-Nielsen K, Muller J, Skakkebaek NE. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS. 1998;106:198–204[discussion 204-6]
  9. Cools M, van Aerde K, Kersemaekers AMF, et al. Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilisation syndromes. J Clin Endocrinol Metab. 2005;[prepublished online] www.endojournals.org
  10. Honecker F, Stoop H, de Krijger RR, Chris Lau YF, Bokemeyer C, Looijenga LH. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol. 2004;203:849–857
  11. Stoop H, Honecker F, Cools M, de Krijger RR, Bokemeyer C, Looijenga LHJ. Differentiation and development of human female germ cells during prenatal gonadogenesis: an immunohistochemical study. Hum Reprod. 2005;20:1466–1476
  12. Rajpert-De Meyts E, Skakkebaek NK. Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours. Int J Androl. 1994;17:85–92
  13. Hustin J, Collette J, Franchimont P. Immunohistochemical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumours. Int J Androl. 1987;10:29–35
  14. Looijenga LH, Stoop H, de Leeuw HP, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003;63:2244–2250
  15. Schnieders F, Dork T, Arnemann J, Vogel T, Werner M, Schmidtke J. Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet. 1996;5:1801–1807
  16. Castrillon DH, Quade BJ, Wang TY, Quigley C, Crum CP. The human VASA gene is specifically expressed in the germ cell lineage. Proc Natl Acad Sci U S A. 2000;97:9585–9590
  17. Duan WR, Garner DS, Williams SD, Funckes-Shippy CL, Spath IS, Blomme EA. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol. 2003;199:221–228
  18. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining bases on microwave oven heating of tissue sections. J Histochem Cytochem. 1991;39:741–748
  19. Looijenga LH, Oosterhuis JW. Pathobiology of germ cell tumors: views and news. Anal Quant Cytol Histol. 2002;24:263–279
  20. Rajpert-De Meyts ER, Jorgensen N, Muller J, Skakkebaek NK. Prolonged expression of the c-kit receptor in germ cells of intersex fetal testes. J Pathol. 1996;178:166–169
  21. Rajpert-De Meyts E, Hanstein R, Jorgensen N, Graem N, Vogt PH, Skakkebaek NK. Developmental expression of POU5F1 (OCT3/4) in normal and dysgenetic human gonads. Hum Reprod. 2004;19:1338–1344
  22. Lau Y, Chou P, Iezzoni J, Alonzo J, Komuves L. Expression of a candidate gene for the gonadoblastoma locus in gonadoblastoma and testicular seminoma. Cytogenet Cell Genet. 2000;91:160–164
  23. Strohmeyer T, Reese D, Press M, Ackermann R, Hartmann M, Slamon D. Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J Urol. 1995;153:511–515
  24. Sperger JM, Chen X, Draper JS, et al. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci U S A. 2003;100:13350–13355
  25. Kehler J, Tolkunova E, Koschorz B, et al. Oct4 is required for primordial germ cell survival. EMBO Rep. 2004;5:1078–1083
  26. Kersemaekers AMF, Honecker F, Stoop H, et al. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol. 2005;36:512–521
  27. Gidekel S, Pizov G, Bergman Y, Pikarsky E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell. 2003;4:361–370
  28. Vogel T, Schmidtke J. Structure and function of TSPY, the Y-chromosome gene coding for the “testis-specific protein”. Cytogenet Cell Genet. 1998;80:209–213
  29. Modi DN, Sane S, Bhartiya D. Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads. Mol Hum Reprod. 2003;9:219–225
  30. Abir R, Orvieto R, Dicker D, Zukerman Z, Barnett M, Fisch B. Preliminary studies on apoptosis in human fetal ovaries. Fertil Steril. 2002;78:259–264
  31. Johannisson R, Gropp A, Winking H, Coerdt W, Rehder H, Schwinger E. Down's syndrome in the male. Reproductive pathology and meiotic studies. Hum Genet. 1983;63:132–138

☆ This study was financially supported by the ESPE Research Fellowship which is sponsored by Novo Nordisk (Copenhagen, Denmark), the Deutsche Krebshilfe (Bonn, Germany), and the Dutch Cancer Society (Amsterdam, The Netherlands).

PII: S0046-8177(05)00536-8

doi: 10.1016/j.humpath.2005.09.021

Human Pathology
Volume 37, Issue 1 , Pages 101-111 , January 2006

Article Tools

* Image Usage & Resolution